Estimating the health and economic effects of the proposed US Food and Drug Administration voluntary sodium reformulation: Microsimulation cost-effectiveness analysis

BACKGROUND: Sodium consumption is a modifiable risk factor for higher blood pressure (BP) and cardiovascular disease (CVD). The US Food and Drug Administration (FDA) has proposed voluntary sodium reduction goals targeting processed and commercially prepared foods. We aimed to quantify the potential...

Descripción completa

Detalles Bibliográficos
Autores principales: Pearson-Stuttard, Jonathan, Kypridemos, Chris, Collins, Brendan, Mozaffarian, Dariush, Huang, Yue, Bandosz, Piotr, Capewell, Simon, Whitsel, Laurie, Wilde, Parke, O’Flaherty, Martin, Micha, Renata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2018
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892867/
https://www.ncbi.nlm.nih.gov/pubmed/29634725
http://dx.doi.org/10.1371/journal.pmed.1002551

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5892867/
https://www.ncbi.nlm.nih.gov/pubmed/29634725
http://dx.doi.org/10.1371/journal.pmed.1002551

Ejemplares similares